T cell immunoglobulin mucin-3 (TIM-3) was hailed as a new immune checkpoint and had the potential to direct the prognosis; it even presented a great therapeutic effect against tumors in HCC [52]. Here, HAVCR2 is linked to hepatocellular carcinoma.